What Are Krystal Biotech Inc.'s Key Financial Figures?
| Fiscal year | FY2025 ended December 31, 2025 | FY2024 ended December 31, 2024 | FY2023 ended December 31, 2023 | FY2022 ended December 31, 2022 |
|---|---|---|---|---|
| Revenue | $389 million | $291 million | $51 million | $0 |
| Operating income | $161 million | $66 million | -$110 million | -$145 million |
| Operating margin | 41.5% | 22.6% | -216.2% | n/a |
| Net income | $205 million | $89 million | $11 million | -$140 million |
| Net margin | 52.6% | 30.7% | 21.6% | n/a |
| Operating cash flow | $201 million | $123 million | -$89 million | -$101 million |
| Capital expenditures | $12 million | $4 million | $12 million | $53 million |
| Free cash flow | $189 million | $119 million | -$101 million | -$154 million |
Operating margin widened by 18.8 percentage points between fiscal 2024 and 2025, which separates pricing and cost discipline from revenue growth alone. Free cash flow (operating cash flow minus capital expenditures) was $189 million against net income of $205 million; cash generation fell short of reported earnings, which is worth reconciling in the cash flow statement.
What Does Krystal Biotech Inc.'s Balance Sheet Show?
| Cash and cash equivalents | $496 million |
|---|---|
| Long-term debt | Not reported |
| Total assets | $1.3 billion |
| Total liabilities | $114 million |
| Shareholders' equity | $1.2 billion |
| Current ratio | 10.0x |
Balance sheet values are as of the end of fiscal 2025. Income statement figures describe a whole year; balance sheet figures describe a single day, so the two answer different questions.
Where These Numbers Come From
Every figure on this page is a value Krystal Biotech Inc. reported in its own SEC filings, read from the SEC's XBRL data (accession 0001711279-26-000016 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 7, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary.
Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation.
Frequently Asked Questions
What was Krystal Biotech Inc.'s revenue in fiscal 2025?
Krystal Biotech Inc. reported revenue of $389 million for the fiscal year ended December 31, 2025, according to its SEC filings.
What is Krystal Biotech Inc.'s operating margin?
Krystal Biotech Inc.'s operating margin was 41.5% in fiscal 2025: operating income of $161 million on revenue of $389 million.
How much free cash flow did Krystal Biotech Inc. generate?
Operating cash flow of $201 million less capital expenditures of $12 million gives free cash flow of $189 million for fiscal 2025.